Jan 13, 2014

Posted by in Featured, Stock Market News | 0 Comments

Stocks Gaining Momentum: Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG), EnPro Industries, Inc. (NYSE:NPO), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), IsoRay, Inc. (NYSEMKT:ISR)

Stocks Gaining Momentum: Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG), EnPro Industries, Inc. (NYSE:NPO), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), IsoRay, Inc. (NYSEMKT:ISR)

Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) jumped more than 25 percent in the current trading session after the company reported that it has inked a master service provider deal with an undisclosed major biopharmaceutical firm. ROSG shares are trading in the range of $3.82 to $4.37 today. The company has a market capitalization of $39.18 million.

EnPro Industries, Inc. (NYSE:NPO) made a new 52-week high of $80.00 in the current trading session after Oppenheimer lifted its price target for the company from $65 per share to $92 per share, in a research note sent to investors on Monday. NPO shares are trading in the range of $72.12 to $80.00 today. The company has a market capitalization of $1.56 billion and P/E ratio of $60.26.

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) jumped 36.84 percent to $1.56 today on volume of 24.21 million shares. The 52-week range of the stock is $0.28 to $1.74. RNN shares jumped more than 175 percent in the past five days that brought the biopharmaceutical firm under the spotlight. The company has a market capitalization of $238.42 million.

IsoRay, Inc. (NYSEMKT:ISR) rose 17.02 percent to $0.653, on volume of 1.94 million shares, in the current trading session. The 52-week range of the stock is $0.42 to $0.85. IsoRay is engaged in the development, manufacturing and sale of isotope-based medical products and devices, which are used in the treatment of cancer and some other malignant diseases. The company has a market capitalization of $25.09 million.

Comments are closed.